Sunday, 17 May 2020

Immuno Oncology







When Cancer Cells Meets Immune Cells


Cancer Neutralizes Immune Cells

T cell Inhibition On Meeting Cancer 

Cancer Makes You To Loose Your Immunity






PDL 1 Protein In Cancer Cells Stops Killer T Cells Activation






PDL 1 Pathway blocks Immune Response Down-Regulating T cell






Anti PD 1 Protein Activates Tumour Killing 



Theory To Practice

PD1/PDL1 Inhibition Block T Cell Inhibition







Pembrolizumab aka Keytruda 

Anti PD1 

Keys Open Locks 








Milestones In Immuno - Oncology





 Oncology In 2019




Immuno Oncology 120 Billion Dollar Market

Drugs In Pipeline




Snapshot






No comments:

Post a Comment